LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_006218.4:c.3172A>T
PIK3CA
· NP_006209.2:p.(Ile1058Phe)
· NM_006218.4
GRCh37: chr3:178952117 A>T
·
GRCh38: chr3:179234329 A>T
Gene:
PIK3CA
Transcript:
NM_006218.4
Final call
VUS
PS4 supporting
PM1 supporting
PM2 supporting
Variant details
Gene
PIK3CA
Transcript
NM_006218.4
Protein
NP_006209.2:p.(Ile1058Phe)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
VUS: PS4 Supporting reflects 2.0 raw VCEP tumor-occurrence points, capped at Supporting.
2
VUS: PM1 Supporting places p.Ile1058Phe within the approved PIK3CA kinase domain at residues 797-1068.
3
VUS: PM2 Supporting reflects absence from the qualifying GNOMAD_V2_1 control dataset.
Final determination:
Under ACMG/AMP 2015 Table 5, three supporting pathogenic criteria without any very strong, strong, or moderate criterion do not satisfy a pathogenic or likely pathogenic combination, so the call is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: the VCEP excludes PVS1 for this gene. |
cspec
|
| PS1 | Not met | Not met: no alternate-nucleotide p.I1058F variant independently established as pathogenic under BMVCEP criteria was identified. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
PMID:17062663
PMID:33772212
PMID:31842489
PMID:39369133
|
| PS2 | Not assessed | Not assessed: somatic tumor reports lack confirmed parental testing, a relevant affected-tissue proband, and documented CLIA-level high-confidence reporting required by the VCEP. |
cspec
PMID:17062663
PMID:33772212
PMID:31842489
PMID:39369133
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PS3 | Not assessed | Not assessed: the available p.I1058F reports contain no variant-specific functional assay meeting the VCEP's required validation-control and assay-acceptability criteria. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
PMID:17062663
PMID:33772212
PMID:31842489
PMID:39369133
|
| PS4 | Met | Met at Supporting: COSMIC reports 8 tumor occurrences, corresponding to 2.0 raw Table 2A points, with tumor evidence capped by the VCEP at Supporting. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
cosmic
gnomad_v2
gnomad_canada
gnomad_v4
PMID:17062663
|
| PM1 | Met | Met at Supporting: residue 1058 falls within the VCEP-approved PIK3CA kinase-domain interval 797-1068. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
cspec
|
| PM2 | Met | Met at Supporting: the variant is absent from GNOMAD_V2_1, satisfying the VCEP PM2 requirement of absent/rare controls with no more than one observation. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
gnomad_v2
|
| PM3 | N/A | Not applicable: the VCEP states disease-causing variants are heterozygous, so the recessive PM3 criterion is excluded. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PM4 | N/A | Not applicable: the VCEP excludes PM4 for this gene. |
cspec
|
| PM5 | Not met | Not met: zero different missense substitutions at residue 1058 with an independent BMVCEP pathogenic determination were identified. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
pm5_candidates
PMID:17062663
PMID:33772212
PMID:31842489
PMID:39369133
|
| PM6 | N/A | Not applicable: the VCEP directs that PM6 is addressed through PS2 and will not be used separately. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PP1 | N/A | Not applicable: the VCEP excludes PP1 for this disorder because disease-causing variants are germline mosaic, de novo, or mosaic. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PP2 | Not assessed | Not assessed: the required PIK3CA ExAC/gnomAD missense-constraint z-score is unavailable, so the >3.09 threshold cannot be evaluated. |
cspec
|
| PP3 | N/A | Not applicable: the VCEP excludes PP3 for gain-of-function variants, and c.3172A>T produces the missense change p.Ile1058Phe. |
cspec
|
| PP4 | N/A | Not applicable: the VCEP explicitly accounts phenotype specificity under PS4 rather than allowing an independent PP4 call. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PP5 | N/A | Not applicable: the VCEP states that PP5 is not for use under the ClinGen SVI VCEP Review Committee recommendation. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| BA1 | Not assessed | Not assessed: GNOMAD_V2_1 is absent, but GNOMAD_V4_1 frequency is unknown, so the >0.0926% BA1 threshold cannot be evaluated completely. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
gnomad_v2
gnomad_v4
|
| BS1 | Not assessed | Not assessed: GNOMAD_V2_1 is absent, but GNOMAD_V4_1 frequency is unknown, so the >0.0185% BS1 threshold cannot be evaluated completely. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: no homozygote count or well-phenotyped family observations are available to evaluate the VCEP requirement of at least three qualifying observations. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no variant-specific benign functional assay or VCEP-required validation controls were reported for p.I1058F. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
PMID:17062663
PMID:33772212
PMID:31842489
PMID:39369133
|
| BS4 | N/A | Not applicable: the VCEP excludes BS4 because these disorders involve de novo, germline mosaic, or post-zygotic mutations. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| BP1 | N/A | Not applicable: the VCEP excludes BP1 because loss of function is not the disease mechanism for these disorders. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| BP2 | Not assessed | Not assessed: p.I1058F and p.R88Q co-occurred, but phase and the required pathogenic status of the same-gene partner were not established. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
PMID:39369133
PMID:33772212
PMID:17062663
PMID:31842489
|
| BP3 | N/A | Not applicable: the VCEP excludes BP3 for this gene. |
cspec
|
| BP4 | N/A | Not applicable: BP4 is restricted to synonymous, qualifying intronic, or UTR variants, whereas c.3172A>T is an exonic missense change. |
cspec
|
| BP5 | Not met | Not met: available p.I1058F reports are somatic tumors and do not document a cerebral-malformation case with an alternate disease basis in a different gene. |
cspec
PMID:17062663
PMID:33772212
PMID:39369133
PMID:31842489
|
| BP6 | N/A | Not applicable: the VCEP explicitly marks BP6 not applicable for this framework. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous, qualifying intronic, or UTR variant, but c.3172A>T is an exonic missense substitution. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.